IMPLANTABLE INFUSION PUMP
Report
- Report Number
- 3007566237-2017-03333
- Event Type
- Injury
- Date Received
- August 17, 2017
- Date of Event
- September 10, 2003
- Report Date
- August 17, 2017
- Manufacturer
- MEDTRONIC NEUROMODULATION
- Product Code
- LKK
- PMA / PMN Number
- P860004
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- OTHER
Narratives
IT WAS NOT POSSIBLE TO MATCH THIS EVENT WITH ANY PREVIOUSLY REPORTED EVENT. INFORMATION REFERENCES THE MAIN COMPONENT OF THE SYSTEM AND OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: NEU_UNKNOWN_CATH, LOT# SERIAL# UNKNOWN, PRODUCT TYPE: CATHETER. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
STAAL, C., ARENDS, A., HO, S. A SELF-REPORT OF QUALITY OF LIFE OF PATIENTS RECEIVING INTRATHECAL BACLOFEN THERAPY. REHABILITATION NURSING. 2003. 28(5):159-63. DOI: 10.1002/J.2048-7940.2003.TB02050. SUMMARY: THE PURPOSE OF THIS STUDY WAS TO EXPLORE THROUGH A DEPARTMENT QUALITY IMPROVEMENT TOOL A POSSIBLE RELATION BETWEEN QUALITY OF LIFE (QOL), COMPLICATION RATES, AND LENGTH OF INTRATHECAL BACLOFEN (IB) TREATMENT AS REPORTED BY PATIENTS RECEIVING IB THERAPY IN A COMMUNITY BASED REHABILITATION CENTER OUTPATIENT CLINIC. REPORTED EVENTS: THE MOST COMMON COMPLICATIONS CITED WERE INFECTION AND CATHETER BREAKAGE OR DISCONNECT. THE OVERALL INFECTION RATE FOR RESPONDENTS WAS 10% (5 PATIENTS OF THE 49 SURVEYED REPORTED INFECTION). THE MOST COMMON COMPLICATIONS CITED WERE INFECTION AND CATHETER BREAKAGE OR DISCONNECT. THE RATE OF CATHETER BREAKAGE OR DISCONNECT WAS 10%.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 582053 | IMPLANTABLE INFUSION PUMP | PUMP, INFUSION, IMPLANTED, PROGRAMMABLE | LKK | MEDTRONIC NEUROMODULATION | NEU_UNKNOWN_PUMP |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |